Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.53
0.01 (0.12%)
At close: Aug 18, 2025, 3:59 PM
8.54
0.12%
Pre-market: Aug 19, 2025, 07:15 AM EDT
Y-mAbs Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.52M | 20.9M | 26.5M | 18.46M | 22.8M | 19.93M | 23.36M | 20.45M | 20.75M | 20.25M | 31.45M | 12.54M | 10.8M | 10.49M | 9.6M | 8.96M | 10.95M | 5.38M |
Cost of Revenue | 2.66M | 3M | 7.84M | 2.25M | 3.01M | 2.15M | 2.04M | 2.65M | 4.65M | 2.08M | 2.02M | 2.48M | 1.24M | 1.83M | 1.46M | 550K | 410K | 93K |
Gross Profit | 16.86M | 17.9M | 18.65M | 16.21M | 19.78M | 17.78M | 21.32M | 17.81M | 16.1M | 18.17M | 29.43M | 10.06M | 9.56M | 8.65M | 8.14M | 8.41M | 10.54M | 5.29M |
Operating Income | -5.6M | -6.54M | -5.94M | -8.57M | -9.79M | -6.91M | -3.2M | -7.75M | -7.22M | -7.5M | -1.15M | -26.02M | -39.95M | -27.7M | -35.76M | -28.7M | -22.71M | -28.26M |
Interest Income | n/a | 1.35M | -1.61M | 1.92M | 640K | 439K | 2.41M | 189K | 1.1M | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.23M | -5.19M | -7.54M | -6.65M | -9.15M | -6.47M | -793K | -7.56M | -6.12M | -6.39M | 1.16M | -27.53M | -41.13M | -28.07M | -36.89M | -28.86M | -22.94M | 33.41M |
Net Income | -3.24M | -5.2M | -6.79M | -7M | -9.25M | -6.63M | -988K | -7.75M | -6.3M | -5.1M | 1.16M | -29.04M | -42.32M | -28.44M | -36.89M | -28.86M | -22.94M | 33.41M |
Selling & General & Admin | 11.31M | 13.09M | 12.38M | 13.61M | 17.23M | 11.43M | 11.13M | 10.2M | 11.27M | 12.25M | 10.79M | 13.63M | 23.08M | 13.44M | 15.14M | 13.99M | 13.47M | 11.97M |
Research & Development | 11.1M | 11.36M | 12.21M | 11.17M | 12.34M | 13.27M | 13.39M | 15.36M | 12.05M | 13.42M | 19.79M | 22.45M | 26.42M | 22.91M | 28.76M | 23.13M | 19.78M | 21.58M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210K | n/a | n/a | n/a |
Operating Expenses | 22.42M | 24.45M | 24.59M | 24.78M | 29.57M | 24.69M | 24.52M | 25.56M | 23.32M | 25.67M | 30.58M | 36.08M | 49.5M | 36.35M | 43.9M | 37.12M | 33.25M | 33.55M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.51M | 1.19M | 373K | 1.14M | 154K | 225K | 338K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.08M | 27.45M | 32.43M | 27.03M | 32.59M | 26.84M | 26.56M | 28.2M | 27.97M | 27.75M | 32.6M | 38.55M | 50.74M | 38.18M | 45.36M | 37.67M | 33.66M | 33.64M |
Income Tax Expense | 7K | 5K | -752K | 346K | 100K | 160K | 195K | 187K | 179K | -1.29M | n/a | 1.51M | 1.19M | 373K | n/a | n/a | -216K | n/a |
Shares Outstanding (Basic) | 45.32M | 45.1M | 44.88M | 44.63M | 44.02M | 43.78M | 43.63M | 43.62M | 43.66M | 43.67M | 43.67M | 43.69M | 43.72M | 43.71M | 43.6M | 43.6M | 43.28M | 41.87M |
Shares Outstanding (Diluted) | 45.32M | 45.1M | 44.88M | 44.63M | 44.02M | 43.78M | 43.63M | 43.62M | 43.66M | 43.67M | 44.69M | 43.72M | 43.72M | 43.71M | 43.6M | 43.6M | 43.57M | 44.38M |
EPS (Basic) | -0.07 | -0.12 | -0.15 | -0.16 | -0.21 | -0.15 | -0.02 | -0.18 | -0.14 | -0.12 | 0.03 | -0.66 | -0.97 | -0.65 | -0.85 | -0.66 | -0.53 | 0.80 |
EPS (Diluted) | -0.07 | -0.12 | -0.15 | -0.16 | -0.21 | -0.15 | -0.02 | -0.18 | -0.14 | -0.12 | 0.03 | -0.66 | -0.97 | -0.65 | -0.85 | -0.66 | -0.53 | 0.75 |
EBITDA | -5.6M | -6.54M | -5.83M | -8.45M | -9.64M | -6.75M | -3.04M | -7.58M | -7M | -7.5M | -923K | -25.79M | -39.95M | -27.5M | -35.47M | -28.56M | -22.5M | -28.13M |
EBIT | -3.23M | -5.19M | -5.94M | -8.57M | -9.79M | -6.91M | -3.2M | -7.75M | -7.22M | -7.5M | -1.15M | -26.02M | -41.13M | -27.7M | -35.76M | -28.7M | -22.71M | 33.75M |
Depreciation & Amortization | n/a | 71K | 102K | 121K | 153K | 159K | 161K | 168K | 224K | 182K | 230K | 226K | 188K | 195K | 291K | 145K | 216K | 130K |